Evaluation of effects of pomegeranate seed oil on lipid profiles, apolipoproteines and body composition in subjects with low HDL-C concentrations

Research Institute for Endocrine Science, Shaheed Beheshti University of Medical Sciences0 个研究点目标入组 150 人开始时间: 待定最近更新: 2018年2月22日

适应症

试验速览

暂无简介。

•willingness to cooperate; ages 20-70 years; those with 35= BMI (kg/m2) =25; having levels of HDL-C <40mgr/dl in the last 12 months; Who are placed in stage I and stage II on TLC, according to NCEP ATP III criteria; Diabetic people not used Glitazones and insulin or consume constantly oral diabetes medications for at least three months Even if taking anti-lipid medications (statins and fibers); Lack of breastfeeding and pregnancy; Those who have had less than 5 Kg in body weight in the last 3 months; Not having any thyroid disorders and kidney failure; Lack of any severe mental illness; Not having cancer in the past five years; Lack of peptic ulcer disease; No smoking and alcohol; Not using drugs affecting lipid profile such as corticosteroids, cyclosporine, propranolol and glucocorticoid. Exclusion criteria: weight loss >10Kg during the study, Diagnosis of any of the diseases mentioned in inclusion criteria, during the study; Patient's lack of cooperation in each of the stages studied.

发起方

Research Institute for Endocrine Science, Shaheed Beheshti University of Medical Sciences